Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.78
-0.03 (-0.44%)
At close: Aug 19, 2025, 11:44 AM
Day One Biopharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -30.32M | -36M | -65.71M | 37.04M | -4.41M | -62.41M | -54.51M | -46.15M | -45.86M | -42.39M | -40.11M | -37.8M | -36.53M | -27.75M | -21.94M | -19.24M | -15.47M | -16.1M |
Depreciation & Amortization | 886K | 819K | 759K | 746K | 408K | 116K | 103K | 99K | 92K | 89K | 180K | 165K | 133K | 53K | 51K | 50K | 49K | 49K |
Stock-Based Compensation | 10.9M | 12.86M | 11.04M | 11.55M | 13.03M | 12.64M | 10.81M | 9.61M | 9.48M | 9.45M | 6.83M | 8.58M | 5.63M | 6.2M | 5.1M | 5.15M | 2.54M | 538K |
Other Working Capital | -260K | -27.39M | 32.23M | -46.67M | 58.34M | -989K | 4.62M | 199K | -805K | 3.09M | 2.5M | 3.34M | 1.24M | 972K | 2.58M | 1.48M | -186K | -2.72M |
Other Non-Cash Items | -4M | -4.17M | -2.82M | 53.62M | -96.72M | 9.38M | -43.15M | 46.15M | -9.48M | -599K | -999K | -1.03M | -262K | n/a | -19K | 5K | 7K | 8.01M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 41.58M | -45.79M | 4.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.27M | -32.51M | 26.73M | -52.21M | 50.74M | 1.22M | 3.8M | -975K | -879K | 7.47M | -1.22M | 6.87M | 979K | -71K | 3.64M | 1.82M | -525K | -2.24M |
Operating Cash Flow | -24.81M | -59M | -30.01M | 50.75M | -49.13M | -49.73M | -41.37M | -37.06M | -42.43M | -25.98M | -35.31M | -23.21M | -29.79M | -21.56M | -13.17M | -12.22M | -13.41M | -9.74M |
Capital Expenditures | 3.5M | -3.82M | -1.42M | -55.72M | -17.13M | n/a | -8K | -3.04M | -149K | -26K | n/a | -4K | -7K | -15K | 8M | n/a | n/a | -8M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -2.99M | 3M | -20.42K | 11.17K | n/a | -20M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -238.5M | -189.8M | -275.22M | -214.63M | -121.6M | -47.16M | -99.14M | -79.96M | -104.73M | -160.01M | -121.37M | -266.85M | -5.99M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 264.8M | 161M | 7M | 202.66M | 47.78M | 136.45M | 129.53M | 171.91M | 125.15M | 148.85M | 119.16M | 20M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 32K | -3.5M | -17.1M | -55M | 108M | 89.29M | 2.99M | -3M | 20.42K | -11.17K | -2.21K | 20M | -5.99M | n/a | -8M | n/a | n/a | n/a |
Investing Cash Flow | 26.32M | -32.61M | -269.64M | -67.7M | 17.06M | 89.29M | 30.38M | 88.92M | 20.27M | -11.19M | -2.21M | -246.85M | -6M | -15K | 8M | n/a | n/a | -8M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 748K | n/a | n/a | n/a | n/a | n/a | 1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 318K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 1.85M | 21.92M | 1.3M | 48K | 597K | 115K | 162.1M | 1.18M | 1.92M | 2.05M | 161.93M | n/a | 318K | n/a | 168.53M | -872K |
Financial Cash Flow | 748K | n/a | 1.85M | 200.09M | 1.3M | 48K | 597K | 115K | 162.1M | 1.18M | 1.92M | 2.05M | 161.93M | n/a | 318K | -615K | 168.53M | 128.88M |
Net Cash Flow | 2.26M | -91.61M | -297.8M | 183.15M | -30.77M | 39.61M | -10.39M | 51.97M | 139.94M | -35.99M | -35.6M | -268.01M | 126.15M | -21.58M | -12.85M | -12.84M | 155.13M | 111.14M |
Free Cash Flow | -21.31M | -62.81M | -31.43M | -4.97M | -66.25M | -49.73M | -41.38M | -40.1M | -42.58M | -26.01M | -35.31M | -23.22M | -29.79M | -21.58M | -5.17M | -12.22M | -13.41M | -17.74M |